A comparison of two products to decrease the incidence of MASD/IAD

by moisture are often characterized by an inflammation which may or may not be seen as skin erosion (loss of some or all of the epidermis leaving a denuded surface) or cutaneous secondary skin infection.Although the prevalence of MASD/IAD is widely varied, incidences of fecal and urinary incontinence and other forms of Perineal dermatitis are generally high among older people and long term care residents with up to 50% of these individuals experiencing the problem at some point of their lives. Moisture-associated skin damage (MASD) is both painful and costly and the costs associated with urinary incontinence alone currently estimated to be over $26.3 billion annually. MASD/IAD has significant implications to patient care and may result in a number of issues including pain, secondary skin infections and misidentification, which can lead to ineffective treatment plans. In a study conducted by Junkins and Selekof (2007), 24 patients had fecal incontinence and 23 of those patients developed IAD. MASD/IAD increases a patients risk for pressure ulcer development (Driver, 2007). Numerous previous studies have shown that the use of preventive methods may decrease the incidence of MASD/IAD. However, there is a still research gap and it is uncertain as to which products are more effective. The purpose of this study is to critically investigate the feasibility of using Cavilon no sting barrier film in reducing the Prevalence of MASD/IAD.The primary goal of this study is to determine the effectiveness of the Cavilon no sting barrier film spray compared to the use of Aloe-Vesta skin ointment in critically ill patients that are incontinent. The other specific objectives include:The research question is: Can Cavilon no sting barrier film be used as an effective medication in reducing the prevalence of Moisture-associated skin damage MASD/ incontinence associated dermatitis (IAD)?Previous studies by Denat and Khorshid (2011) and Beeckman, Verhaeghe, Defloor,